Search

Ali M. Imam

Examiner (ID: 14135)

Most Active Art Unit
3737
Art Unit(s)
3737
Total Applications
818
Issued Applications
688
Pending Applications
87
Abandoned Applications
43

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16748728 [patent_doc_number] => 20210100737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => TRANSDERMAL DELIVERY OF DRONABINOL [patent_app_type] => utility [patent_app_number] => 17/062332 [patent_app_country] => US [patent_app_date] => 2020-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8664 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17062332 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/062332
TRANSDERMAL DELIVERY OF DRONABINOL Oct 1, 2020 Abandoned
Array ( [id] => 17149451 [patent_doc_number] => 11142513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-12 [patent_title] => Method for simultaneously preparing 2-ethoxyphenol and 1,3-benzodioxolane-2-one [patent_app_type] => utility [patent_app_number] => 17/028290 [patent_app_country] => US [patent_app_date] => 2020-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1664 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028290 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/028290
Method for simultaneously preparing 2-ethoxyphenol and 1,3-benzodioxolane-2-one Sep 21, 2020 Issued
17/026375 IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4(PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION Sep 20, 2020 Abandoned
Array ( [id] => 16710274 [patent_doc_number] => 20210077421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => TREATMENT OF SYNGAP1 ENCEPHALOPATHY [patent_app_type] => utility [patent_app_number] => 17/022494 [patent_app_country] => US [patent_app_date] => 2020-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7497 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17022494 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/022494
TREATMENT OF SYNGAP1 ENCEPHALOPATHY Sep 15, 2020 Abandoned
Array ( [id] => 17378111 [patent_doc_number] => 11236108 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-01 [patent_title] => Functionalized heterocycles as antiviral agents [patent_app_type] => utility [patent_app_number] => 17/022660 [patent_app_country] => US [patent_app_date] => 2020-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12388 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17022660 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/022660
Functionalized heterocycles as antiviral agents Sep 15, 2020 Issued
Array ( [id] => 20142860 [patent_doc_number] => 12377175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-05 [patent_title] => Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies [patent_app_type] => utility [patent_app_number] => 17/016189 [patent_app_country] => US [patent_app_date] => 2020-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30141 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016189 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/016189
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies Sep 8, 2020 Issued
Array ( [id] => 20142860 [patent_doc_number] => 12377175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-05 [patent_title] => Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies [patent_app_type] => utility [patent_app_number] => 17/016189 [patent_app_country] => US [patent_app_date] => 2020-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30141 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016189 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/016189
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies Sep 8, 2020 Issued
Array ( [id] => 20142860 [patent_doc_number] => 12377175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-05 [patent_title] => Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies [patent_app_type] => utility [patent_app_number] => 17/016189 [patent_app_country] => US [patent_app_date] => 2020-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30141 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016189 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/016189
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies Sep 8, 2020 Issued
Array ( [id] => 20142860 [patent_doc_number] => 12377175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-05 [patent_title] => Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies [patent_app_type] => utility [patent_app_number] => 17/016189 [patent_app_country] => US [patent_app_date] => 2020-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30141 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016189 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/016189
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies Sep 8, 2020 Issued
Array ( [id] => 16525126 [patent_doc_number] => 20200399206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => METHODS AND COMPOSITIONS FOR TERPENOID TRICYCLOALKANE SYNTHESIS [patent_app_type] => utility [patent_app_number] => 17/013902 [patent_app_country] => US [patent_app_date] => 2020-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26372 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013902 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/013902
Methods and compositions for terpenoid tricycloalkane synthesis Sep 7, 2020 Issued
Array ( [id] => 17851870 [patent_doc_number] => 20220281912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => COMPOUNDS FOR USE IN THE TREATMENT OF LIVER DISEASE [patent_app_type] => utility [patent_app_number] => 17/630291 [patent_app_country] => US [patent_app_date] => 2020-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15689 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630291 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/630291
Compounds for use in the treatment of liver disease Aug 13, 2020 Issued
Array ( [id] => 16466642 [patent_doc_number] => 20200368179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-26 [patent_title] => USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY [patent_app_type] => utility [patent_app_number] => 16/989605 [patent_app_country] => US [patent_app_date] => 2020-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5698 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16989605 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/989605
USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY Aug 9, 2020 Abandoned
Array ( [id] => 17163006 [patent_doc_number] => 11149093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-19 [patent_title] => Antibodies to symmetrically dimethylated arginine analytes and use thereof [patent_app_type] => utility [patent_app_number] => 16/988418 [patent_app_country] => US [patent_app_date] => 2020-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 23970 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16988418 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/988418
Antibodies to symmetrically dimethylated arginine analytes and use thereof Aug 6, 2020 Issued
Array ( [id] => 16468292 [patent_doc_number] => 20200369829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-26 [patent_title] => METHOD FOR PREPARING POLYOLS [patent_app_type] => utility [patent_app_number] => 16/987153 [patent_app_country] => US [patent_app_date] => 2020-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16747 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16987153 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/987153
METHOD FOR PREPARING POLYOLS Aug 5, 2020 Abandoned
Array ( [id] => 16452463 [patent_doc_number] => 20200361889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => FUNCTIONALIZED BIO-BASED CROSSLINKERS [patent_app_type] => utility [patent_app_number] => 16/986283 [patent_app_country] => US [patent_app_date] => 2020-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7490 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986283 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/986283
Functionalized bio-based crosslinkers Aug 5, 2020 Issued
Array ( [id] => 16908928 [patent_doc_number] => 11040953 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-22 [patent_title] => Process for the preparation of a diarylthiohydantoin compound [patent_app_type] => utility [patent_app_number] => 16/939976 [patent_app_country] => US [patent_app_date] => 2020-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5060 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939976 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/939976
Process for the preparation of a diarylthiohydantoin compound Jul 26, 2020 Issued
Array ( [id] => 19196546 [patent_doc_number] => 11993775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-28 [patent_title] => Ubiquitin-specific peptidase 24 inhibitor, medicinal composition and method of delaying or reversing multidrug resistance in cancers using the same [patent_app_type] => utility [patent_app_number] => 16/939543 [patent_app_country] => US [patent_app_date] => 2020-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 68 [patent_no_of_words] => 6371 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939543 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/939543
Ubiquitin-specific peptidase 24 inhibitor, medicinal composition and method of delaying or reversing multidrug resistance in cancers using the same Jul 26, 2020 Issued
Array ( [id] => 16435569 [patent_doc_number] => 20200352894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => COMBINATION THERAPY [patent_app_type] => utility [patent_app_number] => 16/937916 [patent_app_country] => US [patent_app_date] => 2020-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42967 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16937916 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/937916
COMBINATION THERAPY Jul 23, 2020 Abandoned
Array ( [id] => 16570495 [patent_doc_number] => 20210009501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/936256 [patent_app_country] => US [patent_app_date] => 2020-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13088 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936256 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/936256
Treprostinil derivatives and compositions and uses thereof Jul 21, 2020 Issued
Array ( [id] => 17837650 [patent_doc_number] => 20220274955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS [patent_app_type] => utility [patent_app_number] => 16/932072 [patent_app_country] => US [patent_app_date] => 2020-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67775 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16932072 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/932072
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders Jul 16, 2020 Issued
Menu